Our Blog

Our Blog

The Impact of Omega Monopure 1300 EC on Cholesterol and Cardiovascular Wellness

michael-burton-ceo-of-covenant-health-product
4 minute read

Listen to article
Audio generated by DropInBlog's Blog Voice AI™ may have slight pronunciation nuances. Learn more

Table of Contents

Omega Monopure 1300 EC is a supplement designed by Xymogen to support cardiovascular wellness and cholesterol. Its 60-softgel variant has been clinically approved, meaning that it is a reliable source of health support. How may it impact your health? Is it a good choice? Find it out in this article.

Omega Monopure 1300 EC—Basic Information

Before we discuss cardiovascular wellness and cholesterol, let’s introduce Omega Monopure 1300 EC. What do you know about this supplement?

These vary only based on the number of softgels—their formula is the same. Since we are on this topic, let’s look at the ingredient list.

  • MaxSimil Fish Oil Concentrate—1.3 g,
  • Total Omega-3 Fatty Acids—860 mg,
  • EPA (eicosapentaenoic acid)—600 mg,
  • DHA (docosahexaenoic acid)—260 mg.

The MaxSimil fish oil deserves more attention here. According to Xymogen, it has a three times greater EPA/DHA absorption rate than an equivalent dose of ethyl ester fish oils used in other supplements. The supplement does not contain many common allergens, including:

  • wheat,
  • gluten,
  • corn,
  • yeast,
  • soy protein,
  • dairy,
  • shellfish,
  • peanuts,
  • tree nuts,
  • eggs,
  • GMOs.

As a result, you may take it even if you suffer from the most common food allergies. How often should you take it? Xymogen recommends one softgel per day. Naturally, your dosage may differ based on your healthcare provider's prescription.

Omega Monopure 1300 EC vs. Cholesterol and Cardiovascular Wellness

With all the basic information behind us, we may now look at the impact of Omega Monopure 1300 EC on your cholesterol and cardiovascular wellness. How may this supplement support your health?

Omega Monopure 1300 EC and Cholesterol

Whether fish oil may or may not help with lowering bad cholesterol levels is debatable—there is conflicting scientific evidence, so this topic needs to be researched further.

However, there is evidence that fish oil promotes high-density lipoprotein (HDL) production. This substance, also known as “good” cholesterol, is important for your health, so in the end, Omega Monopure 1300 EC might have a slightly positive impact on cholesterol, though we would not overestimate its impact overall.

Omega Monopure 1300 EC and Cardiovascular Wellness

When it comes to cardiovascular wellness, Omega Monopure 1300 EC might help when already suffering from cardiovascular conditions. It all goes down to its contents—there is much more EPA than DHA in this supplement, which makes it a choice worth considering based on the most current research. Why is it so?

Currently, there is no relevant research on the impact of DHA on cardiovascular health, while we know that EPA may be beneficial. Therefore, it is possible that DHA may neutralize the impact of EPA; hence, it is best to use EPA-dominant supplements, such as Omega Monopure 1300 EC.

The Takeaway

As you can see, Omega Monopure 1300 EC may support “good” cholesterol production and have a positive effect on your cardiovascular wellness if you already suffer from certain conditions. Nevertheless, you shouldn’t take this supplement on your own. Instead, contact your health practitioner first to ensure that it will provide you with the health support you need. You should also remember that supplements do not substitute for a balanced diet, and avoiding processed and fat foods will help you reduce your cholesterol levels naturally.

Do you want to learn more about Omega Monopure 1300 EC by Xymogen? Book our FREE product consultation!

Omega MonoPure 1300 EC

Omega MonoPure 1300 EC

$65.99

Omega MonoPure 1300 EC by Xymogen Omega MonoPure 1300 EC 60 sg by Xymogen includes a naturally enhanced form of fish oil called MaxSimil® monoglyceride...… Click here to read more

References:

  1. Lavie, C. J., Milani, R. V., & Mehra, M. R. (2009). Omega-3 polyunsaturated fatty acids and cardiovascular diseases. Journal of the American College of Cardiology, 54(7), 585-594. https://doi.org/10.1016/j.jacc.2009.02.084
  2. Davidson, M. H., Stein, E. A., Bays, H. E., Maki, K. C., Doyle, R. T., Shalwitz, R. A., Ballantyne, C. M., & Ginsberg, H. N. (2011). Effect of fish oil supplementation on serum triglycerides, LDL cholesterol, and LDL subfractions in hypertriglyceridemic adults. Journal of Clinical Lipidology, 5(6), 483-492. https://doi.org/10.1016/j.jacl.2011.08.006
  3. Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Ishikawa, Y., Oikawa, S., ... & Kitagawa, A. (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. The Lancet, 369(9567), 1090-1098. https://doi.org/10.1016/S0140-6736(07)60527-3

« Back to Blog